Effects of pre-transplant L-carnitine supplementation on primary graft dysfunction in liver transplant recipients: a pilot, randomized, placebo-controlled clinical trial

• Principais autores: Behrouz Khajeh (Autor), Simin Dashti-Khavidaki (Autor), Mohsen Nasiri-Toosi (Autor), Keyhan Mohammadi (Autor), Atefeh Jafari (Autor)
• Formato: Livro
• Publicado em: Wolters Kluwer Medknow Publications, 2019-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Primary graft dysfunction (PGD) and non-function (PNF) happen in 8.7-24.7% and 0.9-7.2% of liver transplant recipients, respectively. These phenomena increase treatment cost and patients' death. This study assessed the effect of L-carnitine supplementation on the incidences of PNF/PGD in liver...